Editorial
Second-generation drug-eluting stents versus bare-metal stents in saphenous vein grafts: is the choice more complicated than before?
Abstract
Saphenous vein grafts (SVGs) are still commonly used for surgical revascularization of coronary arteries although are related to poor long-term patency rates (1-4). “Full arterial” revascularization in coronary artery bypass graft (CABG) procedures, despite related to an improved clinical outcome, is still seldom achieved (5-7).